Exact Sciences
EXAS
#1106
Rank
โ‚ฌ18.25 B
Marketcap
95,61ย โ‚ฌ
Share price
0.00%
Change (1 day)
105.07%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -5,08ย โ‚ฌ

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -4,85ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -5,08ย โ‚ฌ.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-5,08ย โ‚ฌ0.08%
2024-5,08ย โ‚ฌ
2022-3,23ย โ‚ฌ2.31%
2021-3,15ย โ‚ฌ-38.54%
2020-5,13ย โ‚ฌ692.96%
2019-0,65ย โ‚ฌ-50.69%
2018-1,31ย โ‚ฌ44%
2017-0,91ย โ‚ฌ-39.39%
2016-1,50ย โ‚ฌ-2.94%
2015-1,55ย โ‚ฌ37.1%
2014-1,13ย โ‚ฌ79.71%
2013-0,63ย โ‚ฌ-21.59%
2012-0,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,81ย โ‚ฌ-137.23%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
1,45ย โ‚ฌ-129.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,31ย โ‚ฌ-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-1,24ย โ‚ฌ-74.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-46,39ย โ‚ฌ 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA